Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-005582 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
40,638
Total Value
$1,027,292.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's title: SVP General Counsel and Corporate Secretary | Common Stock | โ | Feb 2, 2026 | Sale | 7,983 | $25.50 | $203,553.73 | 142,658 | Direct | โ | View Details | |
Reporting Person's title: SVP General Counsel and Corporate Secretary | Common Stock | โ | Feb 2, 2026 | Sale | 8,562 | $24.97 | $213,793.14 | 134,096 | Direct | โ | View Details | |
Reporting Person's title: SVP General Counsel and Corporate Secretary | Common Stock | โ | Feb 2, 2026 | Sale | 19,379 | $25.24 | $489,125.96 | 114,717 | Direct | โ | View Details | |
Reporting Person's title: SVP General Counsel and Corporate Secretary | Common Stock | โ | Feb 2, 2026 | Sale | 4,714 | $25.63 | $120,819.82 | 110,003 | Direct | โ | View Details |